N-(2-(2-(2-(acetamido)ethoxy)ethoxy)ethyl)-2-(7-(dimethylamino)-2-oxo-2H-chromen-4-yl)acetamide | 1186012-93-0

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 香豆素及其衍生物
• 英文名称: N-(2-(2-(2-(acetamido)ethoxy)ethoxy)ethyl)-2-(7-(dimethylamino)-2-oxo-2H-chromen-4-yl)acetamide
• 英文别名: N-[2-[2-(2-acetamidoethoxy)ethoxy]ethyl]-2-[7-(dimethylamino)-2-oxochromen-4-yl]acetamide
• CAS: 1186012-93-0
• 化学式: C₂₁H₂₉N₃O₆
• 分子量: 419.478
• InChiKey: GTRKCDUGORDVEK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.2
• 重原子数：
  30
• 可旋转键数：
  12
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.48
• 拓扑面积：
  106
• 氢给体数：
  2
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  N-(2-(2-(2-(amino)ethoxy)ethoxy)ethyl)-2-(7-(dimethylamino)-2-oxo-2H-chromen-4-yl)acetamide 、 乙酸酐 在 4-二甲氨基吡啶 、 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 2.0h， 以88%的产率得到N-(2-(2-(2-(acetamido)ethoxy)ethoxy)ethyl)-2-(7-(dimethylamino)-2-oxo-2H-chromen-4-yl)acetamide
  参考文献：
  名称：

  Synthetic Analogue of Rocaglaol Displays a Potent and Selective Cytotoxicity in Cancer Cells: Involvement of Apoptosis Inducing Factor and Caspase-12

  摘要：

  Flavaglines constitute a family of natural anticancer compounds. We present here 3 (FL3), the first synthetic flavagline that inhibits cell proliferation and viability (IC50 approximate to 1 nM) at lower doses than did the parent compound, racemic rocaglaol. Compound 3 enhanced doxorubicin cytotoxicity in HepG2 cells and retained its potency against. adriamycin-resistant cell lines without inducing cardiomyocyte toxicity. Compound 3 induced apoptosis of HL60 and Hela cells by triggering the translocation of Apoptosis Inducing Factor (AIF) and caspase-12 to the nucleus. A fluorescent conjugate of 3 accumulated ill endoplasmic reticulum (ER), suggesting that flavaglines bind to their target in the ER. where it triggers a cascade of events that leads to the translocation of AIF and caspase-12 to the nucleus and probably inhibition of eIF4A. Our studies highlight structural features critical to their antineoplastic potential and suggest that these compounds would retain their activity in cells refractory to caspase activation.

  DOI：

  10.1021/jm900365v

文献信息

• Synthetic Analogue of Rocaglaol Displays a Potent and Selective Cytotoxicity in Cancer Cells: Involvement of Apoptosis Inducing Factor and Caspase-12
  作者：Frédéric Thuaud、Yohann Bernard、Gülen Türkeri、Ronan Dirr、Geneviève Aubert、Thierry Cresteil、Aurélie Baguet、Catherine Tomasetto、Yuri Svitkin、Nahum Sonenberg、Canan G. Nebigil、Laurent Désaubry

  DOI：10.1021/jm900365v

  日期：2009.8.27

  Flavaglines constitute a family of natural anticancer compounds. We present here 3 (FL3), the first synthetic flavagline that inhibits cell proliferation and viability (IC50 approximate to 1 nM) at lower doses than did the parent compound, racemic rocaglaol. Compound 3 enhanced doxorubicin cytotoxicity in HepG2 cells and retained its potency against. adriamycin-resistant cell lines without inducing cardiomyocyte toxicity. Compound 3 induced apoptosis of HL60 and Hela cells by triggering the translocation of Apoptosis Inducing Factor (AIF) and caspase-12 to the nucleus. A fluorescent conjugate of 3 accumulated ill endoplasmic reticulum (ER), suggesting that flavaglines bind to their target in the ER. where it triggers a cascade of events that leads to the translocation of AIF and caspase-12 to the nucleus and probably inhibition of eIF4A. Our studies highlight structural features critical to their antineoplastic potential and suggest that these compounds would retain their activity in cells refractory to caspase activation.